|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 14/605 | (2006.01) |
| A61K 38/26 | (2006.01) | ||
| A61P 3/10 | (2006.01) |
| (11) | Number of the document | 1695983 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06114553.8 |
| Date of filing the European patent application | 2001-06-01 | |
| (97) | Date of publication of the European application | 2006-08-30 |
| (45) | Date of publication and mention of the grant of the patent | 2009-03-04 |
| (46) | Date of publication of the claims translation | 2009-06-25 |
| (30) | Number | Date | Country code |
| 212171 P | 2000-06-16 | US | |
| 240349 P | 2000-10-13 | US |
| (72) |
Glaesner, Wolfgang, US
Millican, Rohn, US
|
| (73) |
Eli Lilly & Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Panašaus į gliukagoną peptido-1 analogai |
| Glucagon-like peptide-1 analogs |
| Payment date | Validity (years) | Amount | |
| 2013-06-03 | 13 | 1000.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2014-06-01 |